Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Breast Cancer Research : BCR
|
December 22, 2007
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer
Ern Yu Tan, Leticia Campo, Cheng Han, et al.
The Journal of Biological Chemistry
|
August 11, 2004
Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected]
Ineke P Stolze, Ya-Min Tian, Rebecca J Appelhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer
Ern Yu Tan, Leticia Campo, Cheng Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer
Jane L Boddy, Stephen B Fox, Cheng Han, et al.
The Prostate
|
May 5, 2007
Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia
Alison H Banham, Jane Boddy, Rosalind Launchbury, et al.
Cancer Letters
|
January 12, 2008
Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway
Alexandra Giatromanolaki, Michael I Koukourakis, Francesco Pezzella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma
Stuart C Winter, Ketan A Shah, Leticia Campo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2003
Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression
Jeremy P Braybrooke, Nicola C Levitt, Simon Joel, et al.
Plos One
|
February 25, 2014
Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours
Cameron E Snell, Helen Turley, Alan McIntyre, et al.
Cancer Research
|
May 1, 2002
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients
Nigel J P Beasley, Russell Leek, Mohammed Alam, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Breast Cancer Research : BCR
|
December 22, 2007
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer
Ern Yu Tan, Leticia Campo, Cheng Han, et al.
The Journal of Biological Chemistry
|
August 11, 2004
Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected]
Ineke P Stolze, Ya-Min Tian, Rebecca J Appelhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer
Ern Yu Tan, Leticia Campo, Cheng Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer
Jane L Boddy, Stephen B Fox, Cheng Han, et al.
The Prostate
|
May 5, 2007
Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia
Alison H Banham, Jane Boddy, Rosalind Launchbury, et al.
Cancer Letters
|
January 12, 2008
Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway
Alexandra Giatromanolaki, Michael I Koukourakis, Francesco Pezzella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma
Stuart C Winter, Ketan A Shah, Leticia Campo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2003
Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression
Jeremy P Braybrooke, Nicola C Levitt, Simon Joel, et al.
Plos One
|
February 25, 2014
Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours
Cameron E Snell, Helen Turley, Alan McIntyre, et al.
Cancer Research
|
May 1, 2002
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients
Nigel J P Beasley, Russell Leek, Mohammed Alam, et al.
Page
of 7